IOP Archives - Eye Bulletin

Laser Peripheral Iridotomy Procedure and Its Role in Glaucoma Management

Peripheral iridotomy is an office procedure performed with lasers which involves making a hole in the periphery of the iris to create a communication between posterior chamber (the space between lens and iris) and anterior chamber (the space between iris and cornea). It is mainly used in narrow angle glaucoma and some other conditions (e.g.: plateau iris) where the aqueous needs to flow freely from posterior chamber to anterior chamber. Lasers Used for Iridotomy There [...]

Javed Anwar MS2017-03-07T20:32:59+05:30March 7th, 2017|Prevention, Treatment|0 Comments

Is High Eye Pressure Always Glaucoma?

No. High eye pressure or intraocular pressure (IOP) is not always harmful and not always associated with glaucoma (damage to optic nerve). The normal range of intraocular pressure is traditionally considered to be between 10 and 21 millimeter of mercury (mmHg) but there are people who have high IOP but no glaucoma. This condition is called as ‘Ocular Hypertension’ (OHT). On the other hand, there are some people who have normal eye pressure but they [...]

Javed Anwar MS2017-03-03T17:01:07+05:30February 25th, 2017|Diseases & Conditions, FAQs|0 Comments

Now New Intra-Ocular Pressure Test Could Save The Vision Of Cataract Patients

The eye undergoes fluctuations in intaocular pressure during cataract surgery. The exposure to high pressure may cause damage to the retinal nerve fiber layer and optic nerve. Precisely knowing the intraocular pressure especially at the end of cataract surgery will ensure the high pressure is managed immediately and efficiently to avoid glaucomatous damage to the eye. Professor John Jarstad, of the University of Missouri, said: "The current standard of care following cataract surgery is to [...]

Javed Anwar MS2016-11-18T18:58:05+05:30November 13th, 2016|From the Web|0 Comments

CyPass® Micro-Stent – A New Solution for Glaucoma by Alcon

Alcon has announced the launch of CyPass® Micro-Stent which is implanted in the eye of those who have mild to moderate glaucoma. The stent was developed by Transcend Medical, Inc. which was acquired by Alcon this year (2016). The device has been approved by US Food and Drug Administration for use in primary open-angle glaucoma patients. Sergio Duplan, Region President, North America, Alcon says “This new treatment option for cataract patients with mild to moderate primary open-angle glaucoma has [...]

Javed Anwar MS2016-11-06T10:09:26+05:30October 19th, 2016|New Advancements, News and Events|2 Comments